Objectives: The xCELLigence System Real-Time Cell Analyzer is used for label-free and real-time monitoring of cell proliferation, cytotoxicity, and migration. This system is based on recording the electronic impedance of specially designed plates containing interdigitated gold microelectrodes. Here, we present how to optimize cell proliferation and evaluate cytotoxicity by using the xCELLigence system.
Introduction
Measurement of cell viability is a fundamental step in cell biology. There are many traditional cell viability methods, such as MTT reduction assay and trypan blue assay. By the development of technology, new alternative viability methods with increased sensitivity and specificity have been developed. One of these new methods is the xCELLigence System Real-Time Cell Analyzer. Cellular biological events can be analyzed in real time by the xCELLigence system without labeling (1) . The system measures electronic impedance through micro-electrodes placed on the bottom of well-designed plates. Electronic impedance measurement gives quantitative information about the biological status of cells, such as cell number, viability, morphology, and movement. With the xCELLigence system it is easy to obtain data that can not be obtained by the other traditional endpoint assays.
This current work aims to demonstrate the use of the xCELLigence system for label-free and real-time monitoring of cell viability. Here, we seeded HeLa cells in different numbers and used oxaliplatin, a standard chemotherapeutic agent, to test the cytotoxic effect on HeLa cells.
Methods Chemicals
Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum (FBS), streptomycin/penicillin solution, phosphate-buffered saline (PBS), and trypsin/ EDTA were purchased from PAA Laboratories. Oxaliplatin was obtained from Sigma and dissolved in 0.9% NaCl solution directly. The same volume of 0.9% NaCl solution was added to the media of control groups.
Cell Culture
HeLa cells were maintained in DMEM supplemented with 10% FBS and 0.1 mg/ml -1 streptomycin/ penicillin. Cells were cultured in T25 flasks (Orange scientific) in a humidified incubator with a 5% CO 2 atmosphere at 37°C. When cells reached to 80% confluency, they were trypsinized and seeded on E-plate view with determined counts.
After trypsinizing the cells, media was added to the flask. The cell resuspension was centrifuged at 400 x g for 5 min. The pellet was resuspended with media, and cells were counted by using a hemocytometer.
xCELLigence System
The xCELLigence Real-Time Cell Analyzer System was used according to the manufacturer's instructions (2) . Briefly, the working mechanism of system can be summarized as follows: three specially designed 16-well E-plate views are used in this system. These disposable plates are suitable for single use. On the bottom of the wells, the plates are incorporated with gold microelectrodes. In this modified version of the E-Plate, four rows of microelectrode sensors were removed in the center of each well. This removal leaves space to monitor cells by using microscopy. There is 70% electrode coverage existing on the bottom of the wells. The electronic impedance of these sensor electrodes is recorded to monitor the changes in the cell. Changes in electrical impedance are presented with a unitless parameter called "Cell Index (CI). " When there are no cells in the wells, electrode impedance and CI is 0. After seeding cells, CI will increase. The increase of CI correlates with the increase in attached cell number. When more cells are attached on the surface of E-Plate view, the CI gets higher (Figures 1 and 2 ).
Additionally, instead of cell number, cell viability and strength of cell adhesion can cause changes in CI.
Cell Proliferation Experiment using xCELLigence System
When HeLa cells reached 80% confluency in a T25 flask, the cells were washed with PBS. Then, the cells were treated with 0.05% trypsin/EDTA. After 2 min, 5 mL full media was added to the flask. The cell resuspension was centrifuged at 400 x g for 5 min. The pellet was resuspended with 5 mL media, and the cells were counted by using a hemocytometer.
Before seeding cells in E-Plate view, a standard background was measured by adding 50 μL of full media at 37°C to wells. Then, 4000, 8000, and 16,000 cells per well were seeded in E-plate view, and the total volume of wells was adjusted to 200 µL with media. E-Plate view was incubated for 30 min in a cell culture incubator. Finally, HeLa cells were monitored every 15 min for 48 hours.
Cytotoxicity Experiment using xCELLigence System
Optimum cell cumber for cytotoxicity experiment was determined from the proliferation experiment of HeLa cells; 8000 cells/ well were seeded to each well of E-Plate view. Then, the cells were monitored every 15 min. After 18h, the cells were washed with PBS to remove unattached cells and the media was changed; 3h after changing the media, when cells were in log phase, the cells were treated with 30 µM, 100 µM, 300 µM, and 1 mM oxaliplatin. Cells were monitored for another 24h. Data are presented as a normalized cell index and normalized just after oxaliplatin treatment (CI; normalized at 23h).
Normalized Cell Index (NCI) = CI original /CI normalize time
Statistical Analysis
Calculation of IC 50 value of oxaliplatin was obtained using the software of the xCELLigence RTCA DP system. IC 50 value was expressed as the mean (M)±S.E.M.(n=3).
Results
To observe the effect of cell number on proliferation and determine the optimum cell number for the cytotoxicity experiment, 4000, 8000, and 16,000 cells per well were seeded in the E-plate view. A linear increase of CI values was determined in every single group (Figure 3 ). This increase was in proportion to the number of cells. To examine the cytotoxic effect of oxaliplatin, a standard chemotherapeutic agent, on HeLa cells, we seeded 4000 cells per well of E-Plate view. When cells were in the log phase, they were exposed to 30 µM, 100 µM, 300 µM, and 1 mM oxaliplatin. Oxaliplatin treatment resulted in cell death in a concentration-dependent manner ( Figure 4) ; 30 µM oxaliplatin had no effect on cell viability, whereas 1 mM oxaliplatin induced detachment of all cells 11 h after treatment. The IC 50 value of oxaliplatin was 7.9 x10
M during 24-h treatment in HeLa cells.
Discussion
The aim of this work was to describe the xCELLigence RTCA DP system by monitoring the proliferation of HeLa cells and test the cytotoxic effect of oxaliplatin on HeLa cells.
There are many advantages of the xCELLigence system to other traditional cell-based methods that determine cell proliferation, cytotoxicity, and migration. The xCELLigence system provides label-free detection, which leads cells to be assayed under more physiological conditions and avoids artifacts that can occur by handling. Non-invasive, real-time monitoring of cells allows longterm monitoring of live cells, controlling each well at the same time. This long-term monitoring helps users to determine the optimal time points to perform the assay. Also, different applications can be evaluated in a single plate at the same time.
Additionally, the software of the xCELLigence system allows you to obtain parameters, such as EC 50 , IC 50 , average value of curves, and slope of curves.
The xCELLigence system has various applications. Instead of cell proliferation, cytotoxicity, and invasion/migration assays, the xCELLigence system can also be used for the detection of cellmediated cytotoxicity, virus-mediated cytopatho-genecity, receptor assays, and siRNA knockdown (3).
Conclusion
In conclusion the xCELLigence system can be used for label-free and dynamic monitoring of cellular phenotypic changes in real time. Also, this system has many advantages over traditional cell viability assays.
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